EHS
EHS

First Epoetin alfa Biosimilar Receives FDA Approval for Anemia

Retacrit is the first U.S. biosimilar erythropoiesis-stimulating agent. Although not listed as an interchangeable biosimilar, it is indicated for the same indications as the reference product.
EHS
Back to top button